Daniele Caprioli1, Marco Venniro2, Tamara Zeric3, Xuan Li3, Sweta Adhikary3, Rajtarun Madangopal3, Nathan J Marchant4, Federica Lucantonio5, Geoffrey Schoenbaum3, Jennifer M Bossert3, Yavin Shaham3. 1. Behavioral Neuroscience Research Branch, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, US Department of Health and Human Services, Baltimore, Maryland. Electronic address: daniele.caprioli@nih.gov. 2. Behavioral Neuroscience Research Branch, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, US Department of Health and Human Services, Baltimore, Maryland; Neuropsychopharmacology Laboratory, Section of Pharmacology, Department Public Health and Community Medicine, University of Verona, Verona, Italy. 3. Behavioral Neuroscience Research Branch, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, US Department of Health and Human Services, Baltimore, Maryland. 4. Behavioral Neuroscience Research Branch, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, US Department of Health and Human Services, Baltimore, Maryland; Florey Institute of Neuroscience & Mental Health, University of Melbourne, Parkville, Victoria, Australia. 5. The Solomon H. Snyder Department of Neuroscience, Brain Science Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland.
Abstract
BACKGROUND: Cue-induced methamphetamine craving increases after prolonged forced (experimenter-imposed) abstinence from the drug (incubation of methamphetamine craving). Here, we determined whether this incubation phenomenon would occur under conditions that promote voluntary (self-imposed) abstinence. We also determined the effect of the novel metabotropic glutamate receptor 2 positive allosteric modulator, AZD8529, on incubation of methamphetamine craving after forced or voluntary abstinence. METHODS: We trained rats to self-administer palatable food (6 sessions) and then to self-administer methamphetamine under two conditions: 12 sessions (9 hours/day) or 50 sessions (3 hours/day). We then assessed cue-induced methamphetamine seeking in extinction tests after 1 or 21 abstinence days. Between tests, the rats underwent either forced abstinence (no access to the food- or drug-paired levers) or voluntary abstinence (achieved via a discrete choice procedure between methamphetamine and palatable food; 20 trials per day) for 19 days. We also determined the effect of subcutaneous injections of AZD8529 (20 and 40 mg/kg) on cue-induced methamphetamine seeking 1 day or 21 days after forced or voluntary abstinence. RESULTS: Under both training and abstinence conditions, cue-induced methamphetamine seeking in the extinction tests was higher after 21 abstinence days than after 1 day (incubation of methamphetamine craving). AZD8529 decreased cue-induced methamphetamine seeking on day 21 but not day 1 of forced or voluntary abstinence. CONCLUSIONS: We introduce a novel animal model to study incubation of drug craving and cue-induced drug seeking after prolonged voluntary abstinence, mimicking the human condition of relapse after successful contingency management treatment. Our data suggest that positive allosteric modulators of metabotropic glutamate receptor 2 should be considered for relapse prevention. Published by Elsevier Inc.
BACKGROUND: Cue-induced methamphetamine craving increases after prolonged forced (experimenter-imposed) abstinence from the drug (incubation of methamphetamine craving). Here, we determined whether this incubation phenomenon would occur under conditions that promote voluntary (self-imposed) abstinence. We also determined the effect of the novel metabotropic glutamate receptor 2 positive allosteric modulator, AZD8529, on incubation of methamphetamine craving after forced or voluntary abstinence. METHODS: We trained rats to self-administer palatable food (6 sessions) and then to self-administer methamphetamine under two conditions: 12 sessions (9 hours/day) or 50 sessions (3 hours/day). We then assessed cue-induced methamphetamine seeking in extinction tests after 1 or 21 abstinence days. Between tests, the rats underwent either forced abstinence (no access to the food- or drug-paired levers) or voluntary abstinence (achieved via a discrete choice procedure between methamphetamine and palatable food; 20 trials per day) for 19 days. We also determined the effect of subcutaneous injections of AZD8529 (20 and 40 mg/kg) on cue-induced methamphetamine seeking 1 day or 21 days after forced or voluntary abstinence. RESULTS: Under both training and abstinence conditions, cue-induced methamphetamine seeking in the extinction tests was higher after 21 abstinence days than after 1 day (incubation of methamphetamine craving). AZD8529 decreased cue-induced methamphetamine seeking on day 21 but not day 1 of forced or voluntary abstinence. CONCLUSIONS: We introduce a novel animal model to study incubation of drug craving and cue-induced drug seeking after prolonged voluntary abstinence, mimicking the human condition of relapse after successful contingency management treatment. Our data suggest that positive allosteric modulators of metabotropic glutamate receptor 2 should be considered for relapse prevention. Published by Elsevier Inc.
Authors: Gillinder Bedi; Kenzie L Preston; David H Epstein; Stephen J Heishman; Gina F Marrone; Yavin Shaham; Harriet de Wit Journal: Biol Psychiatry Date: 2011-04-01 Impact factor: 13.382
Authors: B M Siemsen; C M Reichel; K C Leong; C Garcia-Keller; C D Gipson; S Spencer; J A McFaddin; K N Hooker; P W Kalivas; M D Scofield Journal: Neuroscience Date: 2019-03-26 Impact factor: 3.590
Authors: S A Golden; H Aleyasin; R Heins; M Flanigan; M Heshmati; A Takahashi; S J Russo; Y Shaham Journal: Genes Brain Behav Date: 2016-08-18 Impact factor: 3.449
Authors: Xuan Li; Maria B Carreria; Kailyn R Witonsky; Tamara Zeric; Olivia M Lofaro; Jennifer M Bossert; Jianjun Zhang; Felicia Surjono; Christopher T Richie; Brandon K Harvey; Hyeon Son; Christopher W Cowan; Eric J Nestler; Yavin Shaham Journal: Biol Psychiatry Date: 2017-12-29 Impact factor: 13.382
Authors: Sam A Golden; Conor Heins; Marco Venniro; Daniele Caprioli; Michelle Zhang; David H Epstein; Yavin Shaham Journal: Biol Psychiatry Date: 2017-03-17 Impact factor: 13.382